Daniel F. Veber

Molecular Properties That Influence the Oral Bioavailability of Drug Candidates

Daniel F. Veber, Stephen R. Johnson, Hung‐Yuan Cheng et al. · Journal of Medicinal Chemistry · 2002 · 8.1K citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists

B. Evans, Kenneth E. Rittle, Mark G. Bock et al. · Journal of Medicinal Chemistry · 1988 · 1.4K citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

A potent cyclic hexapeptide analogue of somatostatin

Daniel F. Veber, Roger Freidinger, Debra S. Perlow et al. · Nature · 1981 · 413 citations

Pharmacy, Medicinal Chemistry, Pharmacology +8

Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.

B. Evans, Mark G. Bock, Kenneth E. Rittle et al. · Proceedings of the National Academy of Sciences · 1986 · 328 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Acetamidomethyl. A Novel Thiol Protecting Group for Cysteine

Daniel F. Veber, John D. Milkowski, Sándor Varga et al. · Journal of the American Chemical Society · 1972 · 314 citations

Natural Sciences, Biochemistry, Chemistry +8